IQVIA
James Fasano has served as a director of IQVIA since October 2016. Prior to this, Mr. Fasano served as a Director of IMS Health from January 2015 until October 2016. He is a Managing Director responsible for leading CPP Investment Board’s Funds, Secondaries & Co-investments group and previously led CPPIB’s Principal Investing group. Prior to joining CPPIB in 2004, Mr. Fasano worked in the Investment Banking group at Merrill Lynch & Co., focusing on companies in the media and telecommunications sectors. Previously, he was a member of the Mergers & Acquisitions group at RBC Capital Markets and was a Commissioned Officer in the Canadian Armed Forces. Mr. Fasano serves on the boards of directors of NEWAsurion and Cequel Communications, and formerly was a director of AWAS Aviation Capital, LHP Hospital Group and Kinetic Concepts. He has a bachelor’s of Engineering degree from the Royal Military College of Canada and an MBA from the University of Chicago Graduate School of Business. Mr. Fasano chairs the Audit Committee.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
IQVIA
156 followers
IQVIA, formerly Quintiles IMS Holdings, Inc., is an American multinational company serving the combined industries of health information technologies and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.